Overview
This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.
Eligibility
Inclusion Criteria:
- normal participants without eyelid disorders (control group)
- patients with thyroid-associated ophthalmopathy (TAO group)
- cooperative participants
Exclusion Criteria:
- participants with pupil or cornea disorders
- participants with history of eye injury